Our manuscript is highlighted by the limbic

We are very delighted to have our polatuzumab manuscript displayed in the news story in the limbic. The registry is a collaborative effort from our investigators, supporters and management team. We continue to collect quality data and benchmark clinical practice across Australia and New Zealand.